Literature DB >> 30636559

'Good health' as a barrier and facilitator to ART initiation: a qualitative study in the era of test-and-treat in Mozambique.

Amílcar Magaço1, Kathryn Dovel2,3, Fabian Cataldo4, Pedroso Nhassengo1, Risa Hoffman2, Lucas Nerua1, José Tique5, Mohomed Saide1, Aleny Couto5, Francisco Mbofana6, Eduardo Gudo1, Rosa Marlene Cuco7, Sérgio Chicumbe1.   

Abstract

HIV test-and-treat programmes are being implemented throughout sub-Saharan Africa, enrolling HIV-positive clients into antiretroviral treatment (ART) immediately after diagnosis, regardless of clinical stage or CD4 count. This study conducted in Mozambique examined what influenced clients who tested HIV-positive in the context of test-and-treat to make ART initiation decisions. Eighty in-depth interviews with HIV-positive clients and nine focus group discussions with health care workers were completed across 10 health facilities. 'Good health' acted simultaneously as a barrier and facilitator; clients in good health often found a positive HIV diagnosis hard to cope with since HIV was traditionally associated with ill health. Concerns about ART side effects, fear of inadvertent HIV status disclosure and discrimination, limited privacy at health facilities and long waiting times were also barriers to initiation. In contrast, being in good health also acted as a motivator to start treatment so as to remain healthy, maintain responsibilities such as work and caring for dependents and avoid unwanted disclosure. Study findings offer an in-depth understanding of the complex dynamics between individual perceptions of 'being healthy' and its influence on ART initiation within the context of test-and-treat programme implementation.

Entities:  

Keywords:  ART; HIV; Mozambique; Treatment uptake; test and-treat

Year:  2019        PMID: 30636559     DOI: 10.1080/13691058.2018.1535091

Source DB:  PubMed          Journal:  Cult Health Sex        ISSN: 1369-1058


  5 in total

1.  Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study.

Authors:  Ismael Ahmed; Meaza Demissie; Alemayehu Worku; Salem Gugsa; Yemane Berhane
Journal:  HIV AIDS (Auckl)       Date:  2021-11-10

2.  How HIV Clients Find Their Way Back to the ART Clinic: A Qualitative Study of Disengagement and Re-engagement with HIV Care in Malawi.

Authors:  Stephanie Chamberlin; Misheck Mphande; Khumbo Phiri; Pericles Kalande; Kathryn Dovel
Journal:  AIDS Behav       Date:  2021-08-17

3.  'I need time to start antiretroviral therapy': understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia'.

Authors:  Chanda Mwamba; Laura K Beres; Stephanie M Topp; Njekwa Mukamba; Sandra Simbeza; Kombatende Sikombe; Aaloke Mody; Elvin Geng; Charles B Holmes; Caitlin E Kennedy; Izukanji Sikazwe; Julie A Denison; Carolyn Bolton Moore
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

4.  HIV infection in Eastern and Southern Africa: Highest burden, largest challenges, greatest potential.

Authors:  Erica Parker; Melinda A Judge; Eusebio Macete; Tacilta Nhampossa; Jienchi Dorward; Denise C Langa; Caroline De Schacht; Aleny Couto; Paula Vaz; Marco Vitoria; Lucas Molfino; Rachel T Idowu; Nilesh Bhatt; Denise Naniche; Peter N Le Souëf
Journal:  South Afr J HIV Med       Date:  2021-05-28       Impact factor: 2.744

5.  Anti-retroviral therapy after "Treat All" in Harare, Zimbabwe: What are the changes in uptake, time to initiation and retention?

Authors:  Takura Matare; Hemant Deepak Shewade; Ronald T Ncube; Kudzai Masunda; Innocent Mukeredzi; Kudakwashe C Takarinda; Janet Dzangare; Gloria Gonese; Bekezela B Khabo; Regis C Choto; Tsitsi Apollo
Journal:  F1000Res       Date:  2020-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.